Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers.
- DOI
- 10.1016/j.ymthe.2026.08.042
- Published
- 2026 Aug 31
- Container
- Molecular therapy : the journal of the American Society of Gene Therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2026.08.042,
title = {Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers.},
author = {Taifour S and Wong CW and Wallis C and Wang E and Tie AWJ and Woodward E and Waryah C and Hosseinpour M and Lam D and Lister R and Dymond L and Woo A and Houghton PJ and Iyer KS and Norret M and Evans CW and Winteringham L and Gaudieri S and Blancafort P},
year = {2026},
journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
doi = {10.1016/j.ymthe.2026.08.042},
url = {https://doi.org/10.1016/j.ymthe.2026.08.042}
}RIS
TY - JOUR TI - Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers. AU - Taifour S AU - Wong CW AU - Wallis C AU - Wang E AU - Tie AWJ AU - Woodward E AU - Waryah C AU - Hosseinpour M AU - Lam D AU - Lister R AU - Dymond L AU - Woo A AU - Houghton PJ AU - Iyer KS AU - Norret M AU - Evans CW AU - Winteringham L AU - Gaudieri S AU - Blancafort P PY - 2026 JO - Molecular therapy : the journal of the American Society of Gene Therapy DO - 10.1016/j.ymthe.2026.08.042 UR - https://doi.org/10.1016/j.ymthe.2026.08.042 ER -
APA
S, T., CW, W., C, W., E, W., AWJ, T., E, W., C, W., M, H., D, L., R, L., L, D., A, W., PJ, H., KS, I., M, N., CW, E., L, W., S, G., & P, B. (2026). Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR/dCas9 silencers.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.08.042
Source records
- pubmed · retrieved 2026-09-27T08:50:44.938Z